Detalhe da pesquisa
1.
CPT1A induction following epigenetic perturbation promotes MAVS palmitoylation and activation to potentiate antitumor immunity.
Mol Cell
; 83(23): 4370-4385.e9, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38016475
2.
MSCs alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of macrophages in mouse lung organoid-macrophage model.
Cell Mol Life Sci
; 81(1): 124, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466420
3.
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial.
JAMA
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820549
4.
A non-small cell lung carcinoma patient responded to crizotinib therapy after alectinib-induced interstitial lung disease. / é¿æ¥æ¿å°¼æ²»çéå°ç»èèºçæ£è åçé´è´¨æ§èºç¾ç åç¨å åæ¿å°¼æ²»çææ.
Zhejiang Da Xue Xue Bao Yi Xue Ban
; 52(5): 583-587, 2023 Oct 08.
Artigo
em Inglês, Zh
| MEDLINE | ID: mdl-37899398
5.
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patients.
Cancer Immunol Immunother
; 70(12): 3513-3524, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33899131
6.
Localization of Four Allergens in Artemisia Pollen by Immunofluorescent Antibodies.
Int Arch Allergy Immunol
; 179(3): 165-172, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30970365
7.
Crizotinib in patients with anaplastic lymphoma kinase-positive advanced non-small cell lung cancer versus chemotherapy as a first-line treatment.
BMC Cancer
; 18(1): 10, 2018 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29298713
8.
Cell block samples from malignant pleural effusion might be valid alternative samples for anaplastic lymphoma kinase detection in patients with advanced non-small-cell lung cancer.
Histopathology
; 66(7): 949-54, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257756
9.
[Clinicopathological characteristics and imaging features of pulmonary adenocarcinoma with micropapillary pattern].
Zhonghua Zhong Liu Za Zhi
; 36(4): 282-6, 2014 Apr.
Artigo
em Zh
| MEDLINE | ID: mdl-24989915
10.
[Clinicopathological features associated with EGFR gene mutation in non-small cell lung cancer patients].
Zhonghua Yi Xue Za Zhi
; 94(30): 2332-6, 2014 Aug 13.
Artigo
em Zh
| MEDLINE | ID: mdl-25399972
11.
A study on the "Porter Hypothesis" effect of the regulatory measures of the environmental protection tax law in the post-pandemic era.
PLoS One
; 19(5): e0304636, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820316
12.
Epigenetic therapy: Research progress of decitabine in the treatment of solid tumors.
Biochim Biophys Acta Rev Cancer
; 1879(2): 189066, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38163523
13.
Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells.
Nat Commun
; 15(1): 4327, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773088
14.
CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.
J Exp Clin Cancer Res
; 43(1): 134, 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38698468
15.
CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancer.
NPJ Precis Oncol
; 8(1): 25, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297019
16.
Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity.
Signal Transduct Target Ther
; 9(1): 11, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177135
17.
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study.
Cancer Commun (Lond)
; 44(4): 455-468, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421881
18.
Crizotinib overcomes hepatocyte growth factor-mediated resistance to gefitinib in EGFR-mutant non-small-cell lung cancer cells.
Anticancer Drugs
; 24(10): 1039-46, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23962905
19.
Immunomodulatory effects of CDK4/6 inhibitors.
Biochim Biophys Acta Rev Cancer
; 1878(4): 188912, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37182667
20.
[Advances in Diagnosis and Treatment of HER2-positive Non-small Cell Lung Cancer].
Zhongguo Fei Ai Za Zhi
; 26(4): 291-302, 2023 Apr 20.
Artigo
em Zh
| MEDLINE | ID: mdl-37183644